| J.g. Mcginness Prosthetics & Orthot | |
| 1445 Dekalb St, Norristown, Pennsylvania 19401 | |
| (610) 278-1866 |
| Name | J.g. Mcginness Prosthetics & Orthot |
|---|---|
| Organization Name | J G Mcginness Prosthetics & Orthotics Inc |
| Location | 1445 Dekalb St, Norristown, Pennsylvania 19401 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (610) 278-1866 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new study performed in the Netherlands has linked exposure to residential air pollution during fetal life with brain abnormalities that may contribute to impaired cognitive function in school-age children. The study, published in Biological Psychiatry, reports that the air pollution levels related to brain alterations were below those considered to be safe.
Ambulatory systolic blood pressure in the early hours of the morning is predictive of asymptomatic intracranial arterial stenosis, the results of a cross-sectional study in China suggest.
Many patients seem to ignore prescription drug warning labels with instructions that are critical for safe and effective use, according to a study by a Kansas State University researcher working with scientists at Michigan State University.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
Clinical trial results suggest significant benefits with the use of cabozantinib or nivolumab over everolimus for patients with advanced renal cell carcinoma, researchers reported at the European Cancer Congress in Vienna, Austria.
› Verified 4 days ago
| NPI Number | 1316991581 |
| Organization Name | J G MCGINNESS PROSTHETICS & ORTHOTICS INC. |
| Type | Prosthetic/Orthotic Supplier |
| Address | 1445 Dekalb St, Norristown, PA 19401 |
| Phone Number | 610-278-1866 |
News Archive
A new study performed in the Netherlands has linked exposure to residential air pollution during fetal life with brain abnormalities that may contribute to impaired cognitive function in school-age children. The study, published in Biological Psychiatry, reports that the air pollution levels related to brain alterations were below those considered to be safe.
Ambulatory systolic blood pressure in the early hours of the morning is predictive of asymptomatic intracranial arterial stenosis, the results of a cross-sectional study in China suggest.
Many patients seem to ignore prescription drug warning labels with instructions that are critical for safe and effective use, according to a study by a Kansas State University researcher working with scientists at Michigan State University.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
Clinical trial results suggest significant benefits with the use of cabozantinib or nivolumab over everolimus for patients with advanced renal cell carcinoma, researchers reported at the European Cancer Congress in Vienna, Austria.
› Verified 4 days ago
News Archive
A new study performed in the Netherlands has linked exposure to residential air pollution during fetal life with brain abnormalities that may contribute to impaired cognitive function in school-age children. The study, published in Biological Psychiatry, reports that the air pollution levels related to brain alterations were below those considered to be safe.
Ambulatory systolic blood pressure in the early hours of the morning is predictive of asymptomatic intracranial arterial stenosis, the results of a cross-sectional study in China suggest.
Many patients seem to ignore prescription drug warning labels with instructions that are critical for safe and effective use, according to a study by a Kansas State University researcher working with scientists at Michigan State University.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
Clinical trial results suggest significant benefits with the use of cabozantinib or nivolumab over everolimus for patients with advanced renal cell carcinoma, researchers reported at the European Cancer Congress in Vienna, Austria.
› Verified 4 days ago
Sav-on Pharmacy #4727 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2775 W Main St, Norristown, Pennsylvania 19403 Phone: (610) 630-0882 | |
Brown's Ch, Llc Type: Pharmacy Location: 55 E Germantown Pike, Norristown, Pennsylvania 19401 Phone: (610) 313-5507 | |
Carepoint Medical Solutions Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2500 Dekalb Pike, Norristown, Pennsylvania 19401 Phone: (610) 277-1674 | |
The Medicine Shoppe Type: Community/Retail Pharmacy Location: 2113 W Main St, Norristown, Pennsylvania 19403 Phone: (610) 539-7282 | |
Foot Solutions Norristown Type: Durable Medical Equipment & Medical Supplies Supplier Location: 110a W Germantown Pike, Norristown, Pennsylvania 19401 Phone: (610) 270-9600 |